Brunner Stefan M, Itzel Timo, Rubner Christoph, Kesselring Rebecca, Griesshammer Eva, Evert Matthias, Teufel Andreas, Schlitt Hans J, Fichtner-Feigl Stefan
Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.
Institute of Pathology, University Medical Center Regensburg, Regensburg, Germany.
Oncotarget. 2017 Aug 9;8(41):71002-71011. doi: 10.18632/oncotarget.20238. eCollection 2017 Sep 19.
BACKGROUND & AIMS: The immunological microenvironment of HCC influences patient outcome, however, the role of B cells remains unclear. This study investigated effects of local B-cell infiltration in HCC cohorts on patient survival and immunological and molecular tumor microenvironment.
Unsupervised gene expression analysis of full cancer transcriptomes (N=2158) revealed a highly co-regulated immunological cluster in HCC that mainly contained immunoglobulin fragments. More specifically, in an independent patient cohort (N=242) that compares HCC with non tumorous liver tissue high expression of these B-cell associated genes was associated with better patient outcome (P=0.0149). Conclusively, the immunohistochemical analysis of another independent cohort of resected HCCs (N=119) demonstrated that infiltration of HCCs by CD20 cells (P=0.004) and CD79a cells (P=0.038) at the infiltrative margin were associated with prolonged patient survival. Further, the immunoglobulin fragments that were identified in the gene expression analysis were detected at high levels in patients with dense B-cell infiltration.
Gene expression of 2 independent HCC tissue databases was compared using microarrays. Additionally, tissue of resected HCCs was stained for CD20, CD79a and immunoglobulins and analysed for the respective cell numbers separately for tumor, infiltrative margin and distant liver stroma. These findings were correlated with clinical data and patient outcome.
Infiltration of HCCs by B cells is associated with prolonged patient survival. Further, a distinct B-cell like immunoglobulin profile of HCCs was identified that goes along with better patient outcome. We suggest that B cells contribute to local tumor control by secreting increased levels of immunoglobulins with antitumor activity.
肝癌的免疫微环境影响患者预后,然而,B细胞的作用仍不明确。本研究调查了肝癌队列中局部B细胞浸润对患者生存以及免疫和分子肿瘤微环境的影响。
对完整癌症转录组(N = 2158)进行无监督基因表达分析,发现肝癌中存在一个高度共调控的免疫簇,主要包含免疫球蛋白片段。更具体地说,在一个将肝癌与非肿瘤肝组织进行比较的独立患者队列(N = 242)中,这些B细胞相关基因的高表达与更好的患者预后相关(P = 0.0149)。最后,对另一组独立的切除肝癌样本(N = 119)进行免疫组织化学分析表明,浸润边缘的CD20细胞(P = 0.004)和CD79a细胞(P = 0.038)浸润与患者生存期延长相关。此外,在基因表达分析中鉴定出的免疫球蛋白片段在B细胞密集浸润的患者中高水平存在。
使用微阵列比较2个独立肝癌组织数据库的基因表达。此外,对切除的肝癌组织进行CD20、CD79a和免疫球蛋白染色,并分别分析肿瘤、浸润边缘和远处肝基质中各自的细胞数量。将这些发现与临床数据和患者预后相关联。
B细胞浸润肝癌与患者生存期延长相关。此外,还鉴定出一种与更好患者预后相关的独特的类似B细胞的免疫球蛋白谱。我们认为B细胞通过分泌增加水平的具有抗肿瘤活性的免疫球蛋白来促进局部肿瘤控制。